The nutrition of preterm infants

Mario De Curtis1, Jacques Rigo

  • 1Dipartimento di Pediatria e Neuropsichiatria Infantile, Università di Roma La Sapienza, Rome, Italy.

Early Human Development
|January 21, 2012
PubMed

Insights

Optimizing nutrition for very low birthweight (VLBW) infants is crucial. Aggressive nutritional strategies, including high amino acid parenteral nutrition and fortified human milk, support growth and prevent extrauterine growth restriction.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Intensive Care Medicine

Background:

  • Very low birthweight (VLBW) infants often suffer from inadequate nutrient intake, leading to extrauterine growth restriction.
  • Traditional nutritional support may not meet the high demands for growth and development in VLBW infants.
  • Minimizing nutrient interruption at birth is essential for optimal neonatal outcomes.

Purpose of the Study:

  • To review and advocate for aggressive nutritional strategies in VLBW infants.
  • To highlight the importance of early and high amino acid supply.
  • To discuss the role of parenteral and enteral nutrition, including human milk fortification and specialized formulas.

Main Methods:

  • Review of current literature on neonatal nutrition for VLBW infants.
  • Emphasis on parenteral nutrition when enteral feeding is not feasible.
  • Discussion of human milk fortification and alternative preterm formulas.

Main Results:

  • High amino acid supply from day one can prevent catabolism and promote anabolism.
  • Fortified human milk is recommended to meet nutrient needs and support bone mineralization.
  • Specialized cow's milk-based formulas are necessary when human milk is insufficient.

Conclusions:

  • Aggressive nutritional management, including early high amino acid intake, is vital for VLBW infants.
  • Optimizing nutrition through fortified human milk or preterm formulas supports growth and development.
  • Parenteral nutrition plays a critical role when enteral feeding is compromised.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...